Anzeige
Mehr »
Login
Donnerstag, 09.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
GameStop 2.0? ...alle Anzeichen für den nächsten großen Short Squeeze!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
811 Leser
Artikel bewerten:
(2)

Bitget Limited: Bitget Expands BGB Ecosystem with Morph Chain Integration and $1.1M Liquidity Pool on Bulbaswap

Finanznachrichten News

Bitget Expands BGB Ecosystem with Morph Chain Integration and $1.1M Liquidity Pool on Bulbaswap

VICTORIA, Seychelles, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Bitget, the leading cryptocurrency exchange and Web3 company, is excited to announce the cross-chain integration of its native token, Bitget Token (BGB), onto the Morph Chain. This strategic move marks another milestone in expanding BGB's on-chain ecosystem and its commitment to empowering users with expanded accessibility and utility.

With the integration, BGB is now available on the Morph Bridge, facilitating seamless token transfers across multiple blockchains. Bitget has also launched a liquidity pool for BGBon Bulbaswap, the central trading and liquidity marketplace on Morph, with the Total Value Locked (TVL) exceeding $1.1 million within days of its launch. Users can now participate in the liquidity pool to earn rewards while supporting BGB's ecosystem growth.

To incentivize on-chain activities related to BGB, participants of The Great Token Migration (Morph Zoo Season 2) can include BGB in their bridging activities to earn Morph Points. Eligible actions include bridging BGB from Ethereum to Morph, bridging it back from Morph to Ethereum, and holding BGB on Morph to accumulate Season 2 points. Bitget Wallet users benefit from a 1.2x multiplier on bridge scores during the event.

Gracy Chen, CEO of Bitget, commented on the integration: "Our commitment to BGB's long-term growth and utility remains resolute. By bridging BGB to the Morph Chain and introducing new liquidity pools, we are expanding its reach and providing users with more opportunities. This integration aligns with our vision to make BGB a cornerstone of both decentralized and real-world applications, empowering the BGB community to participate in the evolving Web3 ecosystem fully."

The Morph Chain integration is aligned with Bitget's broader strategy to enhance BGB's utility in both on-chain and off-chain scenarios. Recently, Bitget unveiled a new BGB whitepaper, outlining its ambitious plans for the token's future. Key initiatives include a buyback and burn program to establish a deflationary model to support long-term value. The first phase of this initiative has seen 800 million BGB burned, representing 40% of the total supply.

The whitepaper also outlines plans to position BGB as a core asset for staking, liquidity provision, and on-chain DeFi applications. Additionally, Bitget is actively working on integrating BGB into PayFi use cases, enabling real-world utility that includes payments for dining, travel, and shopping via the Bitget Card.

In 2024, BGB demonstrated remarkable growth, achieving a tenfold increase over the year and solidifying its position as one of the best-performing exchange tokens. According to CoinMarketCap, BGB now ranks #25 with a market capitalization of 74 billion.

Morph is an advanced Layer 2 scaling solution built on Ethereum, designed to enhance transaction speed and reduce costs while maintaining Ethereum's security and decentralization. Backed by leading investors such as DragonFly Capital, Pantera Capital, and Foresight Ventures, Morph launched its mainnet in late 2024, introducing seamless cross-chain bridging and supporting a growing ecosystem of decentralized applications (dApps).

About Bitget

Established in 2018, Bitget is the world's leading cryptocurrency exchangeand Web3 company. Serving over 45 million users in 150+ countries and regions, Bitget is committed to helping users trade smarter with its pioneering copy trading feature and other trading solutions, while offering real-time access to Bitcoin price, Ethereum price, and other cryptocurrency prices. Formerly known as BitKeep, Bitget Walletis a world-class multi-chain crypto wallet that offers an array of comprehensive Web3 solutions and features including wallet functionality, token swap, NFT Marketplace, DApp browser, and more.

Bitget is at the forefront of driving crypto adoption through strategic partnerships, such as its role as the Official Crypto Partner of the World's Top Football League, LALIGA, in EASTERN, SEA and LATAM market, as well as a global partner of Turkish National athletes Buse Tosun Çavusoglu (Wrestling world champion), Samet Gümüs (Boxing gold medalist) and Ilkin Aydin (Volleyball national team), to inspire the global community to embrace the future of cryptocurrency.

For more information, visit: Website| Twitter| Telegram| LinkedIn| Discord| Bitget Wallet

For media inquiries, please contact: media@bitget.com

Risk Warning: Digital asset prices are subject to fluctuation and may experience significant volatility. Investors are advised to only allocate funds they can afford to lose. The value of any investment may be impacted, and there is a possibility that financial objectives may not be met, nor the principal investment recovered. Independent financial advice should always be sought, and personal financial experience and standing carefully considered. Past performance is not a reliable indicator of future results. Bitget accepts no liability for any potential losses incurred. Nothing contained herein should be construed as financial advice. For further information, please refer to our Terms of Use.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/4f042830-e0ae-43ad-9503-71c971587134


© 2025 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.